Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Zhao

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Cell|December 30, 2014
Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancerCarlotta Costa, Hiromichi Ebi, Miriam Martini, et al.
Endocrinology|September 17, 2015
The ERα-PI3K Cascade in Proopiomelanocortin Progenitor Neurons Regulates Feeding and Glucose Balance in Female MiceLiangru Zhu, Pingwen Xu, Xuehong Cao, et al.
Cancer Research|May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade GliomasSharmistha Pal, David Kozono, Xiaodong Yang, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Nature Medicine|October 1, 2013
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunitiesMariella Gruber Filbin, Sukriti K Dabral, Maria F Pazyra-Murphy, et al.
Cancer Cell|February 14, 2018
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating MutationsRinath Jeselsohn, Johann S Bergholz, Matthew Pun, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature Communications|February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneitySiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature|February 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolutionSebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Cell|December 30, 2014
Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancerCarlotta Costa, Hiromichi Ebi, Miriam Martini, et al.
Endocrinology|September 17, 2015
The ERα-PI3K Cascade in Proopiomelanocortin Progenitor Neurons Regulates Feeding and Glucose Balance in Female MiceLiangru Zhu, Pingwen Xu, Xuehong Cao, et al.
Cancer Research|May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade GliomasSharmistha Pal, David Kozono, Xiaodong Yang, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Nature Medicine|October 1, 2013
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunitiesMariella Gruber Filbin, Sukriti K Dabral, Maria F Pazyra-Murphy, et al.
Cancer Cell|February 14, 2018
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating MutationsRinath Jeselsohn, Johann S Bergholz, Matthew Pun, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature Communications|February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneitySiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature|February 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolutionSebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler, et al.
Pageof 2